D.A. Davidson & Co. Novartis Ag Transaction History

D.A. Davidson & Co.

$12 Billion
Q3 2024

A detailed history of D.A. Davidson & Co. transactions in Novartis Ag stock. As of the latest transaction made, D.A. Davidson & Co. holds 487,140 shares of NVS stock, worth $50.8 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

487,140

Previous 492,082 1.0%

Holding current value

$50.8 Million

Previous $52.4 Million 6.95%

% of portfolio

0.47%

Previous 0.47%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$106.13 - $120.89 $524,494 - $597,438	-4,942 Reduced 1.0%	487,140 $56 Million
Q2 2024 Jul 31, 2024	SELL	$92.57 - $107.37 $112,935 - $130,991	-1,220 Reduced 0.25%	492,082 $52.4 Million
Q1 2024 May 13, 2024	BUY	$95.27 - $108.47 $593,055 - $675,225	6,225 Added 1.28%	493,302 $47.7 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $931,927 - $1.03 Million	-10,100 Reduced 2.03%	487,077 $49.2 Million
Q3 2023 Nov 08, 2023	BUY	$94.73 - $105.13 $63,374 - $70,331	669 Added 0.13%	497,177 $50.6 Million
Q2 2023 Aug 10, 2023	SELL	$92.52 - $104.91 $1.93 Million - $2.19 Million	-20,901 Reduced 4.04%	496,508 $50.1 Million
Q1 2023 Apr 25, 2023	BUY	$80.03 - $92.81 $2.38 Million - $2.76 Million	29,725 Added 6.1%	517,409 $47.6 Million
Q4 2022 Feb 03, 2023	BUY	$75.55 - $92.52 $288,525 - $353,333	3,819 Added 0.79%	487,684 $44.2 Million
Q3 2022 Nov 07, 2022	BUY	$74.61 - $87.26 $749,308 - $876,352	10,043 Added 2.12%	483,865 $36.8 Million
Q2 2022 Jul 28, 2022	BUY	$80.52 - $93.75 $341,163 - $397,218	4,237 Added 0.9%	473,822 $40.1 Million
Q1 2022 May 12, 2022	BUY	$80.11 - $90.62 $1.61 Million - $1.82 Million	20,123 Added 4.48%	469,585 $41.2 Million
Q4 2021 Jan 31, 2022	BUY	$79.7 - $88.13 $1.25 Million - $1.38 Million	15,638 Added 3.6%	449,462 $39.3 Million
Q3 2021 Nov 15, 2021	BUY	$81.78 - $95.14 $282,549 - $328,708	3,455 Added 0.8%	433,824 $35.5 Million
Q2 2021 Aug 10, 2021	BUY	$85.24 - $94.15 $1.53 Million - $1.68 Million	17,893 Added 4.34%	430,369 $39.3 Million
Q1 2021 May 07, 2021	BUY	$83.5 - $98.47 $5.02 Million - $5.92 Million	60,072 Added 17.05%	412,476 $35.3 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $988,131 - $1.2 Million	12,657 Added 3.73%	352,404 $33.3 Million
Q3 2020 Nov 02, 2020	BUY	$82.14 - $91.0 $1.04 Million - $1.15 Million	12,656 Added 3.87%	339,747 $29.5 Million
Q2 2020 Aug 10, 2020	SELL	$80.93 - $91.1 $4.39 Million - $4.95 Million	-54,306 Reduced 14.24%	327,091 $28.6 Million
Q1 2020 May 05, 2020	BUY	$70.67 - $99.01 $1.8 Million - $2.53 Million	25,513 Added 7.17%	381,397 $31.4 Million
Q4 2019 Feb 14, 2020	BUY	$84.35 - $95.37 $1.36 Million - $1.54 Million	16,123 Added 4.75%	355,884 $33.7 Million
Q3 2019 Nov 05, 2019	BUY	$85.54 - $94.26 $914,165 - $1.01 Million	10,687 Added 3.25%	339,761 $29.5 Million
Q2 2019 Aug 13, 2019	SELL	$75.4 - $92.8 $11.5 Million - $14.2 Million	-152,771 Reduced 31.71%	329,074 $30 Million
Q1 2019 May 13, 2019	BUY	$75.32 - $86.15 $651,743 - $745,455	8,653 Added 1.83%	481,845 $46.2 Million
Q4 2018 Jan 29, 2019	BUY	$73.66 - $82.02 $859,391 - $956,927	11,667 Added 2.53%	473,192 $40.6 Million
Q3 2018 Nov 13, 2018	BUY	$66.94 - $77.43 $1.44 Million - $1.66 Million	21,475 Added 4.88%	461,525 $39.8 Million
Q2 2018 Aug 02, 2018	BUY	$64.91 - $73.36 $644,815 - $728,758	9,934 Added 2.31%	440,050 $33.2 Million
Q1 2018 May 04, 2018	BUY	$70.39 - $84.15 $462,039 - $552,360	6,564 Added 1.55%	430,116 $34.8 Million
Q4 2017 Feb 08, 2018	SELL	$72.33 - $77.64 $6.7 Million - $7.19 Million	-92,577 Reduced 17.94%	423,552 $35.6 Million
Q3 2017 Nov 08, 2017	BUY	$74.14 - $77.27 $250,370 - $260,940	3,377 Added 0.66%	516,129 $44.3 Million
Q2 2017 Aug 11, 2017	BUY	N/A	512,752	512,752 $0

Others Institutions Holding NVS

# of Institutions

1,435

Shares Held

133M

Call Options Held

1.12M

Put Options Held

1.83M

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D.A. Davidson & Co., based on Form 13F filings with the SEC.

News

Stay updated on D.A. Davidson & Co. with notifications on news.

Account